3D Medicines
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Beijing, Beijing, ChinaPhone Number
+86 1067888635Website
www.3d-medicines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About 3D Medicines
3D Medicines, Inc. is a biopharmaceutical company at the stage of late clinical development and early commercialization. With the concept "Help people with cancer live longer and better," aiming for the future long-term survival of tumor patients, 3D Medicines focuses on the development of differentiated next-generation immuno-oncology drugs, to help cancer patients live longer with better quality of life. 3D Medicines has built a pipeline with both innovative biological and small-molecule anti-tumor drugs, and a professional team with global development, registration and commercialization capabilities.Explore more
3D Medicines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is 3D Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at 3D Medicines
Funding: Get notified immidiatlly once 3D Medicines has new funding data
3D Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when 3D Medicines launches new products
Website visits: Recent activity has been detected on your website
Click to see if 3D Medicines had a recent Job posting/layoffs
Earning: See what the market has to say on 3D Medicines recently announced quarterly report
Check out if 3D Medicines is spiking on competitors!
Check if 3D Medicines has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
3D Medicines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
3D Medicines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about 3D Medicines.
3D Medicines Tech Stack
A closer look at the technologies used by 3D Medicines
See more technologies
3D Medicines News & Media
SELLAS Life Sciences Announces Achievement of Development Milestone for Approval of IND for Galinpepimut-S in China
SELLAS to Receive $1 Million Milestone Payment in Second Quarter 2022 SELLAS to Receive $1 Million Milestone Payment in Second Quarter 2022SELLAS Life Sciences Announces IND Acceptance for First Clinical Trial of GPS in China
Chinese Partner, 3D Medicines, Expects to Initiate Trial in Second Half of 2022 in Patients with Hematological Malignancies Who Achieved Objective Response After Receiving Standard TreatmentNEW YORK, Jan. 26, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced that an IND application to initiate theTRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China
First Approval of a Subcutaneously Administered Checkpoint InhibitorTRACON Pharmaceuticals Announces Orphan Drug Designation for Envafolimab in Soft Tissue Sarcoma
Application Included Clinical Trial Data from Soft Tissue Sarcoma Patients Treated with Envafolimab in Phase 1 Trials
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 3D Medicines
Sign Up For FreeTo access detailed company insights
3D Medicines, Inc. is a biopharmaceutical company at the stage of late clinical development and early commercialization. With the concept "Help people with cancer live longer and better," aiming for the future long-term survival of tumor patients, 3D Medicines focuses on the development of differentiated next-generation immuno-oncology drugs, to he... Read More
